基本信息来源于合作网站,原文需代理用户跳转至来源网站获取       
摘要:
Purpose: Nasal lymphoma created dosimetric challenges in radiotherapy due to the complex anatomical structures. This study was to evaluate the efficacy and toxicity of helical Tomotherapy (HT) in the treatment of nasal NK/T-cell lymphoma (NKTCL) patients. Methods and Materials: Between August 2008 and April 2013, a total of 25 NKTCL patients were treated with HT in our department;Among them, three patients have not received chemotherapy, one patient has received concurrent chemo-radiation with CHOP plus L-ASP, two patients have received the sequential chemotherapy regimen following irradiation, and all the others have received 1 - 2 cycles of induction chemotherapy followed by irradiation and then with sequential chemotherapy. CHOP-L with 1 - 7 cycles (median: 4 cycles) was utilized as the main chemotherapy regimen. As for HT, the gross tumor volume (GTV) received target doses (TD) ranging from 50 to 56 Gy (median: 50 Gy) at 2 - 2.78 Gy per fraction;and the clinical target volume (CTV) from 36 to 50 Gy (median: 40 Gy) at 1.6 - 2 Gy per fraction. Results: For those patients who had received irradiation, thirteen achieved complete remission (CR), four partial responses (PR);four had progressive disease (PD), two were lost to follow-up, two died within one month after irradiation and were not followed. In 21 patients with follow-up records, the overall response (CR + PR) was 81.0% with the 3-year survival rate of 87.2%, and the mean survival time was 52.8 months [95% confidence interval (CI): 45.2 - 60.4 months]. After radiotherapy the majority of patients had dry mouth and taste changes in varying degrees, and a small portion of patients had compromised hearing or vision functions. No brain injury symptoms occurred during radiation radiotherapy. Conclusions: As compared with conventional three-dimensional conformal radiotherapy (3D-CRT) and intensity modulated radiation therapy (IMRT) performed with HT, HT appears to have more favorable efficacy and toxicity profiles in the treatment of NKTCL. Further systematic an
推荐文章
肠道NK/T细胞淋巴瘤诊治一例
NK/T细胞淋巴瘤
肠镜
手术
治疗
CHOPE方案结合左旋门冬酰胺酶治疗T细胞淋巴瘤的回顾性分析
淋巴瘤,非霍奇金
淋巴瘤,T细胞
药物疗法
天冬酰胺酶
生存分析
结外NK/T细胞淋巴瘤研究进展
淋巴瘤
自然杀伤细胞
病理学
临床
鼻NK/T细胞淋巴瘤31例临床分析
鼻肿瘤
NK/T细胞淋巴瘤
内容分析
关键词云
关键词热度
相关文献总数  
(/次)
(/年)
文献信息
篇名 Evaluation of Efficacy and Toxicity of Helical Tomotherapy in the Treatment of Patients with Nasal NK/T-Cell Lymphoma
来源期刊 医学物理学、临床工程、放射肿瘤学(英文) 学科 医学
关键词 TOMOTHERAPY NK/T Cell LYMPHOMA IMRT Survival
年,卷(期) 2015,(1) 所属期刊栏目
研究方向 页码范围 32-40
页数 9页 分类号 R73
字数 语种
DOI
五维指标
传播情况
(/次)
(/年)
引文网络
引文网络
二级参考文献  (0)
共引文献  (0)
参考文献  (0)
节点文献
引证文献  (0)
同被引文献  (0)
二级引证文献  (0)
2015(0)
  • 参考文献(0)
  • 二级参考文献(0)
  • 引证文献(0)
  • 二级引证文献(0)
研究主题发展历程
节点文献
TOMOTHERAPY
NK/T
Cell
LYMPHOMA
IMRT
Survival
研究起点
研究来源
研究分支
研究去脉
引文网络交叉学科
相关学者/机构
期刊影响力
医学物理学、临床工程、放射肿瘤学(英文)
季刊
2168-5436
武汉市江夏区汤逊湖北路38号光谷总部空间
出版文献量(篇)
236
总下载数(次)
0
总被引数(次)
0
论文1v1指导